Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Bryan Bennett, David Parry, Stuart Spencer, Helen Mann, Ursula Matulonis
British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2016
Medical writing assistance during the development of this manuscript was provided by Rachel Patel from Mudskipper Business Ltd, funded by AstraZeneca. This work was supported by funding from AstraZeneca.